AXA IM World Access Vehicle ICAV - AXA IM Wave Biotech Fund A Capitalisation EUR (Hedged)

The AXA IM Wave Biotech Fund aims for long-term growth by actively investing in publicly listed companies involved in biotechnology, genomics, and medical research around the world, with a strong focus on U.S.-based firms. The fund's portfolio includes a variety of equity and equity-related securities, such as common stocks, preferred shares, and depository receipts of companies that discover, develop, and commercialize medicines for human use. By targeting firms with the potential for above-average returns, the fund seeks to capitalize on advancements in the biotech and medical sectors.